Sales Force Effectiveness is Dead ... or is it?
Five opportunities for pharma to get ‘back to basics’ and immediately lift sales performance.
Blackdot are a full service benchmarking, consulting, training & advisory firm exclusively focused on lifting sales force effectiveness & efficiency. Blackdot exist to assist their clients to achieve more predictable, repeatable, and sustainable sales performance.
What makes them unique is their total fixation on the use of data-driven, evidence-based techniques to understand what does (and does not) drive sales performance.
By viewing the ‘sales engine’ holistically, as an ecosystem of component parts that work interdependently to impact sales results, Blackdot are able to identify the root cause of what’s inhibiting and enabling your current performance, including quantifying the payoff in actually getting it right.
Armed with this knowledge, Blackdot stand alongside their clients who engage them to define, implement and embed change programs that bridge the gap between ‘hoping’ and ‘knowing’ they’ll deliver top and bottom line performance improvement.
A Sales Force Effectiveness Analysis is used to support the decision making process by providing a detailed overview of the variety of forces that may be acting on an organisational change issue. It allows the user to assess the source and strength of these forces and is particularly useful in the planning and implementation stages of change management.
Pharmaceutical SFE Metrics: Are You Measuring The Wrong Things? (mini)Eularis
With the ever-increasing pressure to ensure maximum return on investment, Sales Force Effectiveness is becoming a high priority area. A Sales Force represents the largest spend in sales and marketing and is second only to Research and Development within the whole of a company. Yet, similar to R & D, study after study shows that the returns gained from this spend are not particularly strong.
Research by Novartis shows, despite the fact that the top 40 Pharmaceutical companies in the US doubled their investment in Sales Force over the past 5 years, prescriptions only rose by 15% in the corresponding time period. Research by IBM concurred with this result and found that every dollar spent on Sales Force generates just $10.30 in sales. This represents a 22% drop in return since 1996.
Generally, there has been an industry-wide decrease in productivity per Sales Representative, down 24% since 1996. In addition, the Sales Representatives that are hired are low in age, output and skill. Reps face a highly competitive field, with recent figures showing a field of 90,000 Reps competing for 650,000 Physicians - only 125,000 of whom are top tier prospects. A rapidly expanding Sales Force with rapidly decreasing productivity results in an approximate 18% turnover each year.
Fortunately, the concept that ‘size sells’ is largely beginning to be abandoned across the Pharmaceutical Industry. Many Sales Managers are turning their attention to increasing the effectiveness of the Sales Force, rather than the size.
In this report, we examine Sales Force Effectiveness in the Pharmaceutical Industry. We analyze current metrics and their limitations, in focus and in measuring Sales Force Effectiveness, for the Pharmaceutical Industry. Then we discuss appropriate metrics to solve these problems, and demonstrate implementation methods and issues.
Pre-Launch Planning: Priming Your Pharma Brand For Profit And Success (mini)Eularis
In today’s environment, Pharmaceutical companies find themselves in a bind. Until recently, if drugs made over $500 Million in annual revenue within 3 to 5 years of launch, they were considered hugely successful. They were a support to an extensive company portfolio and a component of greater company profit.
However, things have changed. The standards for a successful drug have become much higher and much more dangerous. With so many revenue-producing drugs going off patent, companies are facing large holes in their balance sheets and sales that are increasingly slow.
Plus, with the stakes high and available funds low, pipelines are drying up. Add to this the closer scrutiny of safety issues, the rise of Generics, slower physician acceptance and adoption of new therapies, and the Pharma Industry is in trouble.
More and more, companies are expecting marketers to be instrumental at the key moment of launch, and marketers are under extreme pressure. To deliver on the high hopes of Pharmaceutical brand launch, companies must engage in comprehensive pre-launch planning.
In this report we analyze why launch is increasingly important, the issues involved in pre-launch planning, including key organizational strategies, marketing tactics, regulatory considerations, global issues, and methods for ensuring the most effective plans.
Sales Force Effectiveness is Dead ... or is it?
Five opportunities for pharma to get ‘back to basics’ and immediately lift sales performance.
Blackdot are a full service benchmarking, consulting, training & advisory firm exclusively focused on lifting sales force effectiveness & efficiency. Blackdot exist to assist their clients to achieve more predictable, repeatable, and sustainable sales performance.
What makes them unique is their total fixation on the use of data-driven, evidence-based techniques to understand what does (and does not) drive sales performance.
By viewing the ‘sales engine’ holistically, as an ecosystem of component parts that work interdependently to impact sales results, Blackdot are able to identify the root cause of what’s inhibiting and enabling your current performance, including quantifying the payoff in actually getting it right.
Armed with this knowledge, Blackdot stand alongside their clients who engage them to define, implement and embed change programs that bridge the gap between ‘hoping’ and ‘knowing’ they’ll deliver top and bottom line performance improvement.
A Sales Force Effectiveness Analysis is used to support the decision making process by providing a detailed overview of the variety of forces that may be acting on an organisational change issue. It allows the user to assess the source and strength of these forces and is particularly useful in the planning and implementation stages of change management.
Pharmaceutical SFE Metrics: Are You Measuring The Wrong Things? (mini)Eularis
With the ever-increasing pressure to ensure maximum return on investment, Sales Force Effectiveness is becoming a high priority area. A Sales Force represents the largest spend in sales and marketing and is second only to Research and Development within the whole of a company. Yet, similar to R & D, study after study shows that the returns gained from this spend are not particularly strong.
Research by Novartis shows, despite the fact that the top 40 Pharmaceutical companies in the US doubled their investment in Sales Force over the past 5 years, prescriptions only rose by 15% in the corresponding time period. Research by IBM concurred with this result and found that every dollar spent on Sales Force generates just $10.30 in sales. This represents a 22% drop in return since 1996.
Generally, there has been an industry-wide decrease in productivity per Sales Representative, down 24% since 1996. In addition, the Sales Representatives that are hired are low in age, output and skill. Reps face a highly competitive field, with recent figures showing a field of 90,000 Reps competing for 650,000 Physicians - only 125,000 of whom are top tier prospects. A rapidly expanding Sales Force with rapidly decreasing productivity results in an approximate 18% turnover each year.
Fortunately, the concept that ‘size sells’ is largely beginning to be abandoned across the Pharmaceutical Industry. Many Sales Managers are turning their attention to increasing the effectiveness of the Sales Force, rather than the size.
In this report, we examine Sales Force Effectiveness in the Pharmaceutical Industry. We analyze current metrics and their limitations, in focus and in measuring Sales Force Effectiveness, for the Pharmaceutical Industry. Then we discuss appropriate metrics to solve these problems, and demonstrate implementation methods and issues.
Pre-Launch Planning: Priming Your Pharma Brand For Profit And Success (mini)Eularis
In today’s environment, Pharmaceutical companies find themselves in a bind. Until recently, if drugs made over $500 Million in annual revenue within 3 to 5 years of launch, they were considered hugely successful. They were a support to an extensive company portfolio and a component of greater company profit.
However, things have changed. The standards for a successful drug have become much higher and much more dangerous. With so many revenue-producing drugs going off patent, companies are facing large holes in their balance sheets and sales that are increasingly slow.
Plus, with the stakes high and available funds low, pipelines are drying up. Add to this the closer scrutiny of safety issues, the rise of Generics, slower physician acceptance and adoption of new therapies, and the Pharma Industry is in trouble.
More and more, companies are expecting marketers to be instrumental at the key moment of launch, and marketers are under extreme pressure. To deliver on the high hopes of Pharmaceutical brand launch, companies must engage in comprehensive pre-launch planning.
In this report we analyze why launch is increasingly important, the issues involved in pre-launch planning, including key organizational strategies, marketing tactics, regulatory considerations, global issues, and methods for ensuring the most effective plans.
The basics of launching a pharmaceutical drug-
Based on studies done on the practices of 13 top pharmaceutical companies in the world.
For more, write to info@markivmedical.com
Decades ago, Peter Drucker was invited to address the senior management team at General Motors, he asked them a simple, but penetrating question: “Why should I buy a GM car?”
Many senior executives attempted to answer that simple question but, nobody was able to give a convincing answer! The senior managers at General Motors had unlearnt the art of winning customers by not being able to answer the simple question - “Why should I buy a GM car?” But they kept introducing more and more new models which less and less customers bought. And that was the prelude to GM’s decline and bankruptcy.
That question still resonates for every business including Indian Pharma. I wonder how many field sales people - Medical Reps and their managers can answer the question - Why Should the Doctor Rx Your Product? Having a clear answer to that question is the key to winning customers - be they doctors, chemists, distributors or hospitals.
As companies grow larger, hierarchies are created and sales processes like CRM/SFA evolve and become embedded. In the absence of a dynamic top leadership, hierarchy and processes become rigid and difficult to change even though rapidly changing market dynamics demand that they do. Bureaucracy slows down customer-centric decision making and inaction becomes part of the organisation's culture. The emphasis shifts from developing employees and winning customers to launching products and hitting numbers.
Peter Drucker rarely blamed individuals; he saw root causes in the design of organizations—in their structures, processes, norms, and routines. He would ask leaders a few provocative questions: “What is your mission? What should you stop doing? Where has the drive for short-term efficiencies undermined long-term effectiveness? What should be your objectives and guiding principles?”
What is Sales Force Effectiveness and what are the main factors that influence effectiveness of your Sales Force? Where to start when you want to analyze your mature Sales Force and what to look for when you are creating a new sales team?
The Go-To-Market framework is a related set of activities and processes that connect the company’s product strategy to the customer experience. The Go-To-Market framework is cross-functional, spanning product management, product marketing, and sales. It is a strategy and requires operational efficiency.
Description of the ELITE Program based on four pillers: 1. the prescriber insight - 2. the brand preference mix - 3. the the high impact interactions - 4. Job passion
This Presentation help organization in development of his sales teams. As the most important and expensive resource of any organization is his people. So to make his people productive, one should work on their development and make them " Efficiently Effective People". In this presentation , the of importance of " Sales Force Effectiveness Department" in an organization has been established. Every organization want that his sales team should fulfill quantitative objectives of organization. This presentation is specially for pharmaceuticals.
Use this modern go-to-market framework to define the activities required to successfully build market-driven products & services that customers will accept.
Changing Sales Force Behavior To Achieve High PerformanceAmitai Givertz
Slides from an AMG Executive Briefing that revisits "Changing Sales Force Behavior to Achieve High Performance" originally published by Accenture in September, 2003
Training Program for Medical Representatives by Anup Soans Anup Soans
“Hardknocks for GreenHorn is a good book and very useful tool for any one starting his / her career in Pharma Industry..
It covers all basic concepts i.e Medical Part, Sales Tools, Innovative methods and much more. I strongly recommend this book to be the part of freshers training batch in any Pharma Company. .”
How Many Types of Marketing Strategies in Pharma Sector? - Ambit Bio Medixambitbiomedix12
If you are looking to many types of Marketing Strategies in Pharma Sector then Ambit Bio Medix is one of best top 10 pharma franchise companies at the best price. Here are the Many Types of Marketing Strategies in Pharma Sector.
Sales Strategy Plan Powerpoint Presentation SlidesSlideTeam
Introducing Sales Strategy Plan Powerpoint Presentation Slides which allows you to position your products and services in a meaningful way. Mention specific steps that are needed to create a sales plan by utilizing marketing strategies PPT visuals. Understand how to plan for a successful product offering with the help of strategic market planning PowerPoint templates. Analyze the market to determine probable profit and revenue from it by utilizing market opportunity analysis PPT visuals. Discuss in detail four fundamentals of marketing strategy which are price, product, promotion, and place. Monitor progress and prepare for contingencies with the assistance of marketing mix PPT slide deck. Demonstrate the ways to attract your potential customers by using the business plan PPT layouts. Highlight the importance of sales planning and developing strategies in a business organization. Download our ready to use market strategic analysis PPT Presentation and succeed in getting potential customers and retaining them. https://bit.ly/3iSF6mg
Go through this presentation to know about:
1) What every Medical Representative needs to discover before making Doctor Calls?
2) What lays the foundation for healthy prescription growth?
Our Product Marketing Plan Playbook is a planning methodology that highlights our premium tool-kit of tools & templates to develop a comprehensive product marketing plan.
The basics of launching a pharmaceutical drug-
Based on studies done on the practices of 13 top pharmaceutical companies in the world.
For more, write to info@markivmedical.com
Decades ago, Peter Drucker was invited to address the senior management team at General Motors, he asked them a simple, but penetrating question: “Why should I buy a GM car?”
Many senior executives attempted to answer that simple question but, nobody was able to give a convincing answer! The senior managers at General Motors had unlearnt the art of winning customers by not being able to answer the simple question - “Why should I buy a GM car?” But they kept introducing more and more new models which less and less customers bought. And that was the prelude to GM’s decline and bankruptcy.
That question still resonates for every business including Indian Pharma. I wonder how many field sales people - Medical Reps and their managers can answer the question - Why Should the Doctor Rx Your Product? Having a clear answer to that question is the key to winning customers - be they doctors, chemists, distributors or hospitals.
As companies grow larger, hierarchies are created and sales processes like CRM/SFA evolve and become embedded. In the absence of a dynamic top leadership, hierarchy and processes become rigid and difficult to change even though rapidly changing market dynamics demand that they do. Bureaucracy slows down customer-centric decision making and inaction becomes part of the organisation's culture. The emphasis shifts from developing employees and winning customers to launching products and hitting numbers.
Peter Drucker rarely blamed individuals; he saw root causes in the design of organizations—in their structures, processes, norms, and routines. He would ask leaders a few provocative questions: “What is your mission? What should you stop doing? Where has the drive for short-term efficiencies undermined long-term effectiveness? What should be your objectives and guiding principles?”
What is Sales Force Effectiveness and what are the main factors that influence effectiveness of your Sales Force? Where to start when you want to analyze your mature Sales Force and what to look for when you are creating a new sales team?
The Go-To-Market framework is a related set of activities and processes that connect the company’s product strategy to the customer experience. The Go-To-Market framework is cross-functional, spanning product management, product marketing, and sales. It is a strategy and requires operational efficiency.
Description of the ELITE Program based on four pillers: 1. the prescriber insight - 2. the brand preference mix - 3. the the high impact interactions - 4. Job passion
This Presentation help organization in development of his sales teams. As the most important and expensive resource of any organization is his people. So to make his people productive, one should work on their development and make them " Efficiently Effective People". In this presentation , the of importance of " Sales Force Effectiveness Department" in an organization has been established. Every organization want that his sales team should fulfill quantitative objectives of organization. This presentation is specially for pharmaceuticals.
Use this modern go-to-market framework to define the activities required to successfully build market-driven products & services that customers will accept.
Changing Sales Force Behavior To Achieve High PerformanceAmitai Givertz
Slides from an AMG Executive Briefing that revisits "Changing Sales Force Behavior to Achieve High Performance" originally published by Accenture in September, 2003
Training Program for Medical Representatives by Anup Soans Anup Soans
“Hardknocks for GreenHorn is a good book and very useful tool for any one starting his / her career in Pharma Industry..
It covers all basic concepts i.e Medical Part, Sales Tools, Innovative methods and much more. I strongly recommend this book to be the part of freshers training batch in any Pharma Company. .”
How Many Types of Marketing Strategies in Pharma Sector? - Ambit Bio Medixambitbiomedix12
If you are looking to many types of Marketing Strategies in Pharma Sector then Ambit Bio Medix is one of best top 10 pharma franchise companies at the best price. Here are the Many Types of Marketing Strategies in Pharma Sector.
Sales Strategy Plan Powerpoint Presentation SlidesSlideTeam
Introducing Sales Strategy Plan Powerpoint Presentation Slides which allows you to position your products and services in a meaningful way. Mention specific steps that are needed to create a sales plan by utilizing marketing strategies PPT visuals. Understand how to plan for a successful product offering with the help of strategic market planning PowerPoint templates. Analyze the market to determine probable profit and revenue from it by utilizing market opportunity analysis PPT visuals. Discuss in detail four fundamentals of marketing strategy which are price, product, promotion, and place. Monitor progress and prepare for contingencies with the assistance of marketing mix PPT slide deck. Demonstrate the ways to attract your potential customers by using the business plan PPT layouts. Highlight the importance of sales planning and developing strategies in a business organization. Download our ready to use market strategic analysis PPT Presentation and succeed in getting potential customers and retaining them. https://bit.ly/3iSF6mg
Go through this presentation to know about:
1) What every Medical Representative needs to discover before making Doctor Calls?
2) What lays the foundation for healthy prescription growth?
Our Product Marketing Plan Playbook is a planning methodology that highlights our premium tool-kit of tools & templates to develop a comprehensive product marketing plan.
'The Digital Healthcare Leap' highlights insights into how digital health could be an answer to the emerging markets’ challenge to achieve sustainable growth; and leapfrog the developed nations to provide quality, affordable, universal and patient-centric care.
With increased internet and smartphone penetration, and the arrival of new affordable technological solutions in the market, digital healthcare will eventually become a fundamental business imperative. The challenge to healthcare providers for the future, is to adapt and set strategies that leverage new technology while putting patients at the heart of everything they do.
The Singapore Healthcare landscape and advice to health tech players on navigating it, presentation by Dr. Zubin Daruwalla, Health Industries Leader, PwC Singapore, for mHealth Israel, April 30, 2020.
Kenya Medical and Diagnostic Laboratory Service Market Analysis Sample ReportInsights10
This report presents a strategic analysis of the Kenya Medical and Diagnostic Laboratory Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com
The Power of HealthTech - Singapore in One ViewDario Heymann
Today's HealthTech is changing fast - too fast for most of us. Can you still keep the pace? See what was recently discovered and what the status quo is!
Galen Growth Asia is an independent organization with the objective of developing the healthtech ecosystem across Asia through collaboration between all interested
stakeholders. Follow us on Linkedin: https://www.linkedin.com/company/galen-growth-asia or on http://www.galengrowth.asia
This presentation was delivered in IIC - TRPC Forum: Smart Health, IoT and the Empowerment of Patients.
It includes insights from Analysys Mason's 2015 global study of trends in smart health developments, starting from the
challenges and changes in health industry, identifying the
key drivers in these early stages of telehealth development, showing the future outlook, and sharing case studies of early movers in Asia and the rest of the world.
This Power Point Presentation is about the health care industry its opportunities in growing market and the company profile and swot analysis of Apollo Hospitals
This Ipsos healthcare publication provides a summary review of market opportunities related to universal healthcare programmes in ASEAN – with a special focus on Indonesia, Vietnam and the Philippines. As each country’s population joins its national health system, extensive partnerships are needed to fill the demand for hospital beds, qualified doctors, modern equipment, quality medicine and after-sales service.
This healthcare paper takes an up-to-date look at current needs and priorities within these countries’ healthcare plans, along with an analysis of the relevant budgetary and regulatory issues involved.
Email your questions and comments about this healthcare paper to indonesia.bc@ipsos.com
Infectious minds canadian institutes of health research, international infect...Gordon Otieno Odundo
Canadian Institutes of Health Research, International Infectious Disease and Global Health Training Programme (CIHR, IID & GHTP).This is a scholarship program run across four countries: Canada, Colombia, Kenya and India where advanced level students (PhD, Post Doctoral and Clinical fellows) undertake additional training on Infectious Diseases all geared towards being experts in matters pertaining to Global Health. Every month an 'Infectious Minds' sessionis held for two hours via a videoconference link across the four sites. On 15th May 2014 Gordon Otieno Odundo was the Guest Speaker presenting on infectious diseases in children the venue was at the University of Nairobi Institute of Tropical and Infectious Diseases, College of Health Sciences, Kenyatta National Hospital. The audience was primarily Doctoral (PhD) and Post-Doctoral students across the four sites; from Basic Science and Social Science disciplines.
website: http://www.iidandghtp.com/
Discover the innovative and creative projects that highlight my journey throu...dylandmeas
Discover the innovative and creative projects that highlight my journey through Full Sail University. Below, you’ll find a collection of my work showcasing my skills and expertise in digital marketing, event planning, and media production.
Personal Brand Statement:
As an Army veteran dedicated to lifelong learning, I bring a disciplined, strategic mindset to my pursuits. I am constantly expanding my knowledge to innovate and lead effectively. My journey is driven by a commitment to excellence, and to make a meaningful impact in the world.
Explore our most comprehensive guide on lookback analysis at SafePaaS, covering access governance and how it can transform modern ERP audits. Browse now!
[Note: This is a partial preview. To download this presentation, visit:
https://www.oeconsulting.com.sg/training-presentations]
Sustainability has become an increasingly critical topic as the world recognizes the need to protect our planet and its resources for future generations. Sustainability means meeting our current needs without compromising the ability of future generations to meet theirs. It involves long-term planning and consideration of the consequences of our actions. The goal is to create strategies that ensure the long-term viability of People, Planet, and Profit.
Leading companies such as Nike, Toyota, and Siemens are prioritizing sustainable innovation in their business models, setting an example for others to follow. In this Sustainability training presentation, you will learn key concepts, principles, and practices of sustainability applicable across industries. This training aims to create awareness and educate employees, senior executives, consultants, and other key stakeholders, including investors, policymakers, and supply chain partners, on the importance and implementation of sustainability.
LEARNING OBJECTIVES
1. Develop a comprehensive understanding of the fundamental principles and concepts that form the foundation of sustainability within corporate environments.
2. Explore the sustainability implementation model, focusing on effective measures and reporting strategies to track and communicate sustainability efforts.
3. Identify and define best practices and critical success factors essential for achieving sustainability goals within organizations.
CONTENTS
1. Introduction and Key Concepts of Sustainability
2. Principles and Practices of Sustainability
3. Measures and Reporting in Sustainability
4. Sustainability Implementation & Best Practices
To download the complete presentation, visit: https://www.oeconsulting.com.sg/training-presentations
RMD24 | Retail media: hoe zet je dit in als je geen AH of Unilever bent? Heid...BBPMedia1
Grote partijen zijn al een tijdje onderweg met retail media. Ondertussen worden in dit domein ook de kansen zichtbaar voor andere spelers in de markt. Maar met die kansen ontstaan ook vragen: Zelf retail media worden of erop adverteren? In welke fase van de funnel past het en hoe integreer je het in een mediaplan? Wat is nu precies het verschil met marketplaces en Programmatic ads? In dit half uur beslechten we de dilemma's en krijg je antwoorden op wanneer het voor jou tijd is om de volgende stap te zetten.
Affordable Stationery Printing Services in Jaipur | Navpack n PrintNavpack & Print
Looking for professional printing services in Jaipur? Navpack n Print offers high-quality and affordable stationery printing for all your business needs. Stand out with custom stationery designs and fast turnaround times. Contact us today for a quote!
3.0 Project 2_ Developing My Brand Identity Kit.pptxtanyjahb
A personal brand exploration presentation summarizes an individual's unique qualities and goals, covering strengths, values, passions, and target audience. It helps individuals understand what makes them stand out, their desired image, and how they aim to achieve it.
What are the main advantages of using HR recruiter services.pdfHumanResourceDimensi1
HR recruiter services offer top talents to companies according to their specific needs. They handle all recruitment tasks from job posting to onboarding and help companies concentrate on their business growth. With their expertise and years of experience, they streamline the hiring process and save time and resources for the company.
Falcon stands out as a top-tier P2P Invoice Discounting platform in India, bridging esteemed blue-chip companies and eager investors. Our goal is to transform the investment landscape in India by establishing a comprehensive destination for borrowers and investors with diverse profiles and needs, all while minimizing risk. What sets Falcon apart is the elimination of intermediaries such as commercial banks and depository institutions, allowing investors to enjoy higher yields.
1. Moch Kurniawan property all rights reserved.
Sales Force Effectiveness in Pharmaceutical
Moch Kurniawan
2. Moch Kurniawan property all rights reserved.
Globalization, consumerism and prosperity are the
major trends that will impact healthcare in SEA
Globalization
ConsumerismProsperity
Globalization:
• World is becoming smaller: cheap air- travel, connectivity,
internet, medical tourism
• Increased healthcare awareness because of multiple media
Consumerism:
• Increased self medicating behaviour; ease of access (online)
• Increased expression of consumer individuality through brand
choices
Prosperity:
• Increasing disposable income, financial independence leading to
exploring more choices
• Increased health awareness has led to consumers spending more
on health prevention and OTC
2 3
1
Source: Frost & Sullivan
INFRASTRUCTURE
3. Moch Kurniawan property all rights reserved.
APAC among the fastest growing economies over the next 5 years
31.1
20.0
4.9
1.7 0.9 0.3
40.5
21.0
6.2
2.3 1.1
0.3
50.9
23.3
7.9
3.0
1.5
0.4
CAGR
5.1%
CAGR
1.5%
CAGR
5.0%
CAGR
5.7%
CAGR
5.1%
CAGR
2.5%
0
10
20
30
40
50
60
Singapore Brunei Malaysia Thailand Indonesia Vietnam
GDPpercapita(US$thousand)
Southeast Asia
2006 2010 2016
CAGR
3.3%
CAGR
12.0%
CAGR
5.5%
0
10
20
30
40
50
Hong Kong China India
GDPpercapita(US$thousand)
Asia
2006 2010 2016
CAGR
4.8%
CAGR
0.7%
CAGR
1.9%
CAGR
-1.2%
CAGR
1.7%
0
10
20
30
40
50
60
GDPpercapita(US$thousand)
Developed Economies
2006 2010 2016
Source: Data in the above charts were based on GDP per capita data in the respective country’s national currency as sourced from the WEO online database. The data above was converted to US
dollar based on the currency conversion rate for the respective years. Analysis by Frost & Sullivan
CAGR
2.9%
4. Moch Kurniawan property all rights reserved.
Diverse population structures with varying levels
of purchasing power
1.3%
0.5%
1.2%
1.5%
2.7%
2.3%
0.5%
1.6%
0.9%
-0.5%
1.0%
2.1%
-0.2%
2.6%
0.2%
3.9%
0.9%
-0.1%
-0.2%
0.7%
0.4%
0
200
400
600
800
1,000
1,200
1,400
Population(million)
2006 2010 2016
Asia Pacific Mature markets
CAGR (2006-2016F)
Sources: World Economic Outlook (WEO), World Bank and countries data. CAGR data is for 2006 to 2016
Increasing consumer power
•Rural population, low income, relies on
government support.
•Upwardly growing middle class, living in tier 2
cities, educated, can pay for some level of
healthcare
• High income category, first adopters of new
technology, services, private HC
5. Moch Kurniawan property all rights reserved.
Patient Protection and Affordable Care Act (PPACA) Highlights
Source: Ernst & Young LLP
6. Moch Kurniawan property all rights reserved.
NEW GLOBAL CENTER IN
ASIA-PAC
DOCTORS LESS CENTRAL IN
HEALTH
GLOBAL
SYSTEMS
IN CRISIS
PAYERS
FIRMLY
IN CONTROL
1 2 3 4
CUSTOMER
NEAR
UNIVERSAL IPAD ACCESS
HIRING
THE
COMPETITION
FEAR
OF THE
CLOSING DOOR
5 6 7
TRENDS OVERVIEW
TALENT
STRATEGY
THE NEW
REP-RELIANT BLOCKBUSTER
DISCONNECTED DIGITAL
TOOL SET
DETAILING
FOR THE
DOUBLE YES
WORKING
WITH NEW PREFERENCES
8 9 10 11
7. Moch Kurniawan property all rights reserved.
Relevant Trends in Indonesia
• Middle class to rise from 19% of Asian population in 2009 to 30% by
2014
• Indonesia has a young population, where 44% are below 24 years old
Growing wealth of middle class to drive demand
Source: CLSA Mr & Mrs Asia Moving up the J-curves – Spring 2010
8. Moch Kurniawan property all rights reserved.
Toddler
10%
Kids
10%
Teens
9%
Teens
adult
9%
Young
adult
8%
Early
jobber
9%
Young
Parent
8%
Parenthoo
d
8%
Mature
18%
Ageing
well
11%
Age Group Population
Source: sp2010.bps.go.id
Indonesian population per 2010 national census grew at 1.1% YoY. The population pyramid has shown a shift to a bigger young to middle
age group – which resulted to the increasing productive age group between 24 to 54 y.o. The split between Male:Female is almost equal,
except a slightly higher in Female Ageing Well group
Population % based on total age group % based on Gender
Grouping Age Range # of Population Male Female ALL Male Female ALL
Toddler 0-4 22,678,702 10% 9% 10% 51% 49% 100%
Kids 5-9 23,253,480 10% 10% 10% 51% 49% 100%
Teens 10-14 22,671,081 10% 9% 10% 51% 49% 100%
Teens adult 15-19 20,880,734 9% 9% 9% 51% 49% 100%
Young adult 20-24 19,891,633 8% 8% 8% 50% 50% 100%
Early jobber 25-29 21,310,443 9% 9% 9% 50% 50% 100%
Young Parent 30-34 19,830,685 8% 8% 8% 50% 50% 100%
Parenthood 35-39 18,505,131 8% 8% 8% 50% 50% 100%
Mature 40-54 42,127,155 18% 18% 18% 50% 50% 100%
Ageing well 55+ 26,492,282 11% 12% 11% 48% 52% 100%
Total 237,641,326 100% 100% 100% 50% 50% 100%
9. Moch Kurniawan property all rights reserved.
Relevant Trends in Indonesia
Demographic
Indonesian population by Generation Group 2010-2016 (in ‘000)
40,988 41,118 41,247 41,377 41,498 41,595 41,673
103,127 103,233 103,317 103,369 103,353 103,271 103,311
49,305 50,294 51,251 52,192 53,103 53,997 54,893
40,058 41,686 43,360 45,076 46,862 48,708 50,461
-
50,000
100,000
150,000
200,000
250,000
300,000
2010 2011 2012 2013 2014 2015 2016
Gen Z (age 0 - 9) Gen Y (age 10 - 34) Gen X (age 35 - 49) Baby Boomers (age 50 - 75+)
2010 vs 2016
Growth
26.0%
11.3%
0.2%
1.7%
• From the chart above, baby boomers and retire (>54) population have the biggest growth until
2016
people’s life expectancy longer people’s health awareness higher
• Productive people (25 – 54) (gen X and partial gen Y) also growing around 11.3%
Source: Data Statistik Indonesia
10. Moch Kurniawan property all rights reserved.
Indonesia Socio Economic Class - Nielsen & BCG report
Nielsen, the leading global market data provider company, publishes yearly consumer segmentations, called Socio Economic Class (SEC) and the single
measure/ criteria is heavily based on routine Monthly Household Expenditure (MHE). It’s widely used by consumer goods company or any marketer
which targeting consumer/ patient base. It shows the level of economic buying power, from the lowest E class (those who spends MHE below IDR 700K
per month to the highest A class (> IDR 3mio per month). From the past 3 years consecutive data below, it tells us that Indonesian middle economic
classes (AtoC1) are increasing at +6% average, correlates to the economic growth at +6% yoy. This is also aligned with the latest Boston Consulting
Group’s (BCG) report and World Bank’s report on Indonesian middle class
8% 8% 14%
18% 16%
25%
23% 23%
28%
25% 27%
22%
17% 14%
8%9% 12%
3%
2010 2011 2012
Year
E IDR < 700.000
D IDR 700.001 -
1.000.000
C2 IDR 1.000.001 -
1.500.000
C1 IDR 1.500.001 -
2.000.000
B IDR 2.000.001 -
3.000.000
A IDR > 3.000.000
+6%
+9%
+5%
Nielsen’s SES
BCG’s Report
World Bank’s Report –
from the economist.com
11. Moch Kurniawan property all rights reserved.
Population in Indonesia, income demographics 2012 vs 2020
Source: Statistics Indonesia
12. Moch Kurniawan property all rights reserved.
Pharmaceutical and medical technology firms are
not alone in the race
13. Moch Kurniawan property all rights reserved.
• Per capita healthcare expenditure is far below
global average (lowest is Vietnam and
Indonesia).
• Shortage of healthcare professionals in both
countries.
• Efflux of medical tourists seeking treatment in
other countries; 400,000 Indonesians patients
travel annually.
Market Restraints
• Growing middle-class population in Indonesia;
per capita income expected to grow from
$2,580 in 2011 to $3,500 by 2015.
• Rise in non-communicable disease incidence,
cardiovascular disease will account for 31
percent of total number of deaths in Indonesia
by 2030, followed by other chronic diseases at
28 percent.
• Vietnamese government intervention to
enhance healthcare workforce by 2020.
Market Drivers
Total Indonesia Healthcare Market Size
Healthcare Industry: Revenue Forecast Indonesia 2011–2015
Source: Frost & Sullivan analysis.
0.0
2000.0
4000.0
6000.0
8000.0
10000.0
12000.0
2011 2012 2013 2014 2015
Indonesian Healthcare Market Size
Year
Indonesia 5549.30 6016.30 6515.90 7072.10 7742.50
$ (Billion)
CAGR
8.7%
14. Moch Kurniawan property all rights reserved.
3,119
3,453
3,816
4,187
4,755
0
500
1,000
1,500
2,000
2,500
3,000
3,500
4,000
4,500
5,000
2009 2010 2011 2012 2013
SalesValueTrade
OKUYEN(IDR10,583,333,333/OKUYEN)
Nutrition
OTC
ETHICAL
TOTAL MARKET42%
58% 61%
39%
39%
61%
40%
+4%
+9%
+15%
+15% +11%
+13%
+11%
+11%
+14%
39%
61%
+15%
+11%
+12%
60%
Exchange rate: Constant IDR10,583,333,333/OKU YEN
Source: IMS Plus 2013-Q2
Indonesia Pharmaceutical Market – MAT 2013Q2
• Indonesia is a big potential market for pharmaceutical industry, with total market size at OKU YEN 4,755 in MAT 2013Q2
• And the pharmaceutical market in Indonesia has grown rapidly at growth +12% in last year, driven by OTC sector growing +15% in
2013Q2 .
• In overall the pharmaceutical market growth is outperforming economic growth (6%).
• The market growth is expected to continue at the same rate for 2012-2015.
15. Moch Kurniawan property all rights reserved.
Decrease new product launch in Indonesia
Source: IMS: ITMA-Ethical Only MAT 4Q10
0
50
100
150
200
250
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
Number of Products Launch per Year
Foreign Ethical Foreign OTC Local Ethical Local OTC
Avg : 150
Avg : 63
Avg : 33
Avg : 9
16. Moch Kurniawan property all rights reserved.
Most companies have ambitious growth targets - combined
with and increasing complexity in their business model
2013 – Commercial Excellence Forum
18. Moch Kurniawan property all rights reserved.
Indonesia—Healthcare Indicators
Healthcare Indicators: Indonesia, 2007–2011
Key Features
• The population of the country as of 2010 stands at 238.0 million people. It is recorded as the fourth most
populous country in the world.
• The population of the country is expected to grow at a consolidated pace of 1.0 percent for the 2010‒2015
period.
• Life expectancy at birth has increased by 16 months per person from 2007 to 2011, and decreasing mortality
rates are a result of improving healthcare services.
Healthcare Indicators 2007 2008 2009 2010 2011
Population (Million) 226 229 232 238 245
Population Growth Rate (%) 1.3 1.3 1.3 1.07 1.04
Birth Rate (per 1,000) 19.65 19.24 18.84 18.10 17.76
Mortality Rate (per 1,000) 6.90 6.85 6.80 6.28 6.26
Life Expectancy (Female) (years) 72.7 73.1 73.4 74.0 74.3
Life Expectancy (Male) (years) 67.6 68.0 68.3 68.8 69.1
Source: IMF, CIA World Fact Book, Indonesian Department of Health, Frost & Sullivan analysis.
19. Moch Kurniawan property all rights reserved.
Disease Information – Major Causes of Death
Cardiovasc
ular
31.0%
Cummunic
able
13.0%Other
Chronic
28.0%
Cancer
18.0%
Others
10.0%
Major Causes of Death, 2030
Cardiovasc
ular
30.0%
Cummunic
able
25.0%
Other
Chronic
21.0%
Cancer
13.0%
Others
11.0%
Major Causes of Death, 2010
Source: Indonesian Association of Medical Doctors (Ikatan Dokter Indonesia, or IDI)
20. Moch Kurniawan property all rights reserved.
Three dimensions of coverage
Increasing coverage of
41.7% (2005) to 63.2% (2012)
Comprehensive benefit
package
(2012)
No cost sharing
(Jamkesmas)
Ahmad Fuady Health Economics, Policy and Law Erasmus University Rotterdam The Netherlands 2013
21. Moch Kurniawan property all rights reserved.
Three dimensions of coverage
• Less coverage, compared to neighboring countries
• A low coverage to formal workers group
3%
Ahmad Fuady Health Economics, Policy and Law Erasmus University Rotterdam The Netherlands 2013
22. Moch Kurniawan property all rights reserved.
Indonesia Social Security and Healthcare Programs Up Date
Member
• 142.711.701 (24/4/15)
Healthy Facilities
• Central of Healthy
People 9798
• Army Clinic 750
• Police Clinic 570
• Basic Clinic 2712
• Hospital D Class 1675
• Primary Clinic 79
• Pharmacy 1679
• Optic 870
Doctor
• Dentist 1050
• Private Practice 4222
23. Moch Kurniawan property all rights reserved.
Indonesia—Health Care Delivery System
Healthcare System
Public Private
MOH
Hospital
Provincial
Hospital
District
Hospital
Puskesmas
Pustus and
Mobile
Clinics
Specialty
Private
Hospital
General
Private
Hospital
Private
Clinics
Source: Ministry of Health and Frost & Sullivan analysis
24. Moch Kurniawan property all rights reserved.
Indonesia—Hospital Categorization
Hospitals (General and
Specialty)
Public Hospital
Private Hospital
Class A (>400 beds) = 10
Class B (100-400 beds) =
120
Class C (50-100 beds) =
250
Class D (<50 beds) = 126
Extensive specialist medical services +
extensive sub specialists
Extensive specialist medical services +
limited sub specialists
Has minimum of four basic specialist
medical
services
Provides basic medical facilities
Priority
General medical services + specialists and
sub-specialists
Madya
Pratama
Minimum four specialists medical services
General medical service
Source: Indonesian Department of Health, Frost & Sullivan analysis
25. Moch Kurniawan property all rights reserved.
Indonesia—Hospital Classification
Public
(Ministry of
Health)
36%
Public
(Military)
8%
Public (State
or other govt
dept-owned)
5%
Private
51%
Percentof Hospitals by Type and
Sector, Indonesia, 2010
Mental
15.3% Leprosy
6.6%
Pulmonary
TB
3.0%
Eye
3.9%
Maternity
19.5%
Pediatric
32.1%
Others
19.5%
Percent of Specialist Hospitals Split
by Specialty, Indonesia, 2010
Source: Indonesian Department of Health, Frost & Sullivan analysis
Hospital Classification by Type Hospital Classification by Specialty
26. Moch Kurniawan property all rights reserved.
Number of Hospitals: Regional Spread
Source: Ministry of Health, Indonesia
Bali
No. of hospitals:
34
Sumatra Selatan
No. of hospitals:
34
DKI Jakarta
No. of hospitals:
124
Sumatra Utara
No. of hospitals:
130
Sumatra Barat
No. of hospitals:
41
Sulawesi Selatan
No. of hospitals:
62
Jawa Barat
No. of hospitals:
144
Jawa Tengah
No. of hospitals:
162
Aceh
No. of hospitals:
35
Jawa Timur
No. of hospitals:
171
Hospitals are concentrated in major cities in the Sumatra and
Java province, such as Jakarta, Surabaya, Medan.
29. Moch Kurniawan property all rights reserved.
Pharmaceutical companies focus
Source: PricewaterhouseCoopers, Pharma Vision 2020
30. Moch Kurniawan property all rights reserved.
Availability
Availability of trained health care professionals and their
salaries.
• Problem of data validity and reliability
• Lack of health care professionals
• Problem of deployment policy and unclear
decentralization policy
• Without domestically competitive salary
Ahmad Fuady Health Economics, Policy and Law Erasmus University Rotterdam The Netherlands 2013
31. Moch Kurniawan property all rights reserved.
National Health Strategic Plan: Infrastructure Targets
• Aim to increase the number of community health centers from 9,133 in 2010 to 10,856 in 2014
• Develop hospitals to achieve a ratio of 1 bed per 1,000 population in 2014
• Indonesia also aims to achieve sufficient numbers of medical professionals:
Source: Indonesia Human Resource for Health; Development Plan, 2010 Regional Health Forum, 2006
32. Moch Kurniawan property all rights reserved.
Key mega trends impacting Indonesia
Low Probability of Success
DegreeofImpactLowHigh
High
Urbanization
Generation Y
Increase in Working
Age Population
“She-conomy”
The Middle Bulge
Wealth
Watchers
Future
Economic
Growth
Space
Jam
Connectivity
Innovating to
Zero
E-Mobility
Future Infrastructure
Top Industries of
the Future
“Value for Many”
Business Model
Health, Wellness and
Well Being
Future Energy Power
Generation
Private public
partnerships
E-Governance
“Click-n-Connect”
Mobile users
33. Moch Kurniawan property all rights reserved.
What’s Trending for Indonesia Between 2012 and 2015
Indonesia’s per capita expenditure on pharmaceuticals is expected to remain below the US $30 mark by 2015 as
patients continue to be responsible for the bulk of their medical bills
Indonesian health ministry established a supervisory body, the Indonesian Hospitals Supervisory Agency (BPRSI),
in Nov 2011
The University of Indonesia is constructing a new hospital at its Depok campus; the Japan International
Cooperation Agency will provide a loan of $158.0 million to the university to establish UI Hospital
Indonesian Q3 GDP growth came in at a strong 6.5 percent year-on-year for 2011
As of December 2011, the Indonesian health insurance program for the poor, Jamkesmas, covered 76.4 million
people
The goal of JKN is to merge Indonesia’s from 122 million people in 2014 become 257.5 million in 2019
19 % of total healthcare expenditure will be attributed to pharmaceuticals
92 % of drugs on the Essential Drugs List will be low-cost generics
Growth is forecasted to rise to 12% in 2015 and to continue through 2018
200 pharmaceutical manufacturers, of which 70 % are domestic companies and 30 % are multinational
companies
95 % of Indonesia’s drug volume comes from domestic companies
75 % of the industry’s value comes from domestic companies and 25 % comes from multinationals
Source: Frost & Sullivan analysis
34. Moch Kurniawan property all rights reserved.
Examples of investments into Indonesia
Philips supplied most of $140m in
medical equipment for the first
dedicated cancer research centre and
the biggest hospital in Indonesia. Philips,
which has group sales of $32bn and
120,000 employees, has set up a
regional headquarters in Singapore with
almost 300 staff with a view to
increasing its share of the medical and
home healthcare products in Indonesia,
the Philippines and Vietnam.
Singapore-based Invida Group, a specialty
biopharmaceutical company announced a joint
venture with the local Indonesian drug
manufacturer PT MUGI Laboratories. Under the
terms of the agreement, Invida will seek to
expand its operations in Indonesia to include the
importation of raw materials and auxiliaries and
the manufacture of pharmaceutical products.
A state pharmaceutical company PT Bio Farma announced that it is to
spend USD 60 million on a facility to produce blood plasma products,
including albumin and Factor IX. The plant will be the first of its kind in
Indonesia and will be built using assistance from South Korean and
Australian pharmaceutical companies, based on guidelines stipulated by
the WHO.
Sources: Company websites, Frost & Sullivan
Siemens in Indonesia has provided support to public and
private hospitals by installing computed tomography, magnetic
resonance imaging systems, and angiographic systems, as well
as conventional x-ray units and life support systems. Siemens
supplied the first 128-slice computed tomography (CT)
Somatom Definition AS+ in Indonesia.
35. Moch Kurniawan property all rights reserved.
Pharma 3.0 From drugs to healthy outcomes
Ernst & Young – Global Life Sciences Center, Pharma 3.0 Life Sciences Network Basel, 20 May 2010
36. Moch Kurniawan property all rights reserved.
We need to look at the situation from different perspectives…
37. Moch Kurniawan property all rights reserved.
…but at the same time make sure that we have a common
focus
38. Moch Kurniawan property all rights reserved.
Our sales teams are faced with
Less physician
face-to-face
time
Older
products
Fewer new
‘blockbuster’
brands
Increasing
competition –
both generic
and branded
Managed
care and
market access
challenges
Less ‘new’
clinical data
being
provided by
their
companies
Customers’
increasing
use of digital
media to
source
product
information
The 2014 Guide to Improving Your Field Force Coaching Process, www.acoach.net
47. Moch Kurniawan property all rights reserved.
Insight in customer needs makes it possible for us to
identify the right actions and target the execution
2013 – Commercial Excellence Forum
48. Moch Kurniawan property all rights reserved.
There are many customer segmentation methodologies – but we
work with four key methodologies
2013 – Commercial Excellence Forum
49. Moch Kurniawan property all rights reserved.
There are many customer segmentation methodologies – but
we work with four key methodologies
2013 – Commercial Excellence Forum
50. Moch Kurniawan property all rights reserved.
Customer insight is the driver for both customer
segmentation and building your value proposition
2013 – Commercial Excellence Forum
51. Moch Kurniawan property all rights reserved.
Segmentation is needed to drive higher profitability through understanding
customer needs and delivering on those needs
Meet Exceed
Relationship
Development
Retain and
develop
Manage
Customer Expectations
Cherish
and tailor
Numberofindividuals
Few
Many
Low HighValue per individual
Unprofitable Marginally
profitable
More
profitable
Very
profitable
Segmentation is an important tool in becoming customer-centric. It is a key enabler of CRM.
“Recognise me, remember me, value me.”
Typically customers are not created equal ..and different “segments” need different
customer strategies to exploit their value
20-30%
40-50%
20-30%
52. Moch Kurniawan property all rights reserved.
The operational segmentation help prioritization of time and resources
and understand what to offer to who at what price/discount level
2013 – Commercial Excellence Forum
53. Moch Kurniawan property all rights reserved.
Yesterday: Today & Tomorrow:
Targeting Mass customisation Differentiation
Focus Acquisition Retention
Approach How big is my list? Test and learn
Company KPIs Volume targets Value targets
Marketing KPIs Sales volumes Segment objectives (KPIs)
Propositions Sell to all Customer-needs driven
Using segmentation for a ‘Customer Driven Organization’
58. Moch Kurniawan property all rights reserved.
Customer Behavior In Indonesia – 9 Trends
Marketeers Dinner Seminar|Customer Insight Tools | Feb 27-29 2012
59. Moch Kurniawan property all rights reserved.
The foundation for organic growth, is a strong value differentiation which is
perceived valuable by the customers
2013 – Commercial Excellence Forum
60. Moch Kurniawan property all rights reserved.
The value curve can be used to design the customer experience
Finding the Consumer value Curve
66. Moch Kurniawan property all rights reserved.
The key metrics for measuring FFE effectively
understand
demand
master product
knowledge
communicate
business benefits
use account plans
use differentiated
metrics
www.mentorgroup.co.uk
75. Moch Kurniawan property all rights reserved.
Package sale
Dynamic calls
Affiliate
“labs”
2013/142015/beyond
On-the-go
learning
Navigators of
new data
NEW OPPORTUNITIES FOR REP EXPERIENCE
The new, compelling experiences we
can build position reps as quick-
access experts and leverage our
individual affiliates to improve global
strategy.
76. Moch Kurniawan property all rights reserved.
All the
answers
(in best-fit
media)
Influencer
call plans
and content
Flexible
contact
model
Reconnect
marketing
and sales
Feature-rich
engagement
s
REP EXPERIENCE 2015 BEST PRACTICES
Tools, experiences, and expectations
designed to stand out in a crowded
marketplace—or even just a crowded
waiting room
Driver:
Growing Middle-class Population - Indonesian Banks Association, it is estimated that by 2015, the average per capita income in the country will grow to USD 3,500, thus increasing the middle-class population by 10 million.
Rise in Non-communicable Disease Incidence - According to the WHO 2030 forecast, non-communicable diseases will remain the main causes of death in Indonesia. Cardiovascular disease will account for 31% of total number of deaths in 2030, followed by other chronic diseases at 28%. Cancer will be the third largest cause of death in the country accounting for 18% of total deaths.
Government intervention - Vietnam Government’s health care development plan, which extends to 2020, aims at a doctor patient ratio of 8 for every 10,000 patients pharmacists of 2 for every 10,000 patients, and 25 hospital beds for 10,000 patients.
Restraint:
Per capita healthcare expenditure is far below global average (lowest is Vietnam and Indonesia )
Shortage of professionals -
efflux of medical tourists seeking treatment in other countries - 400,000 rich patients travel to neighbouring countries every year for medical treatment due to lack of quality and timely services in Indonesian public hospitals and limited world-class private hospitals in the country
Overall, Indonesia has made steady progress in health outcomes since the early 1970s. For instance, infant mortality dropped from 118 deaths per thousand births in 1970 to about 28.8 in 2010. However, new challenges have emerged in recent years as a result of social and economic changes. The fast rising proportion of more complex non-communicable diseases, insufficient financing for healthcare, and poor accessibility to healthcare are likely to remain the pertinent issues to be addressed by the policymakers in the next decade.
Public healthcare delivery system is decentralised and organised at multiple levels: provincial, district, and sub-districts.
Puskesmas or government primary healthcare centres, are present in all sub-districts. There were more than 8,000 Puskesmas all over Indonesia in 2010. Each Puskesmas has at least one doctor, and the government has been trying to provide a midwife to all the villages. Around 31.0 percent of the Puskesmas provide in-patient facilities as well.
Pustus or health sub-centres were around 22,200. There are about 8,500 mobile health centres as well.
The private sector also provides primary healthcare services, mostly delivered by physicians in private practice and allied health personnel.
In terms of human resources for health, physician workforce is inadequate to meet the needs of the ailing population, and there are severe shortages of specialists while nurses and midwives are better available throughout the country.
General hospitals occupied close to 80 percent of the total hospitals in the country. Despite the rapid increase in non-communicable diseases, specialist hospitals targeting cardiac care and cancer are considerably low at less than one percent of all hospitals. Conversely, hospitals specialising in paediatric care, maternity care, and mental health are most common.
The health system in Indonesia relies heavily on the private sector and this should be given due importance by the government failing which health indicators (infant mortality, maternal mortality and others) will not be improved. Due to lack of infrastructure and skilled workforce in the public sector, most of the population (even the poor) seek private sector treatment for critical services as childbirth, pediatric diarrhoea, and acute respiratory diseases.
Indonesian investment regulations encourage the employment of local workforce for healthcare services. But the shortage of resources makes it very challenging for the hospitals to attract good talent for its operation. So there is a general apprehension in the minds of foreign investors about the quality of service that could be provided due to lack of local resources. With the intention to boost its healthcare manpower, the Indonesia Ministry of Health has prescribed a series of manpower target ratios in the MOH Strategic Plan 2005 to 2009 for the major categories of healthcare professions by 2010. Based on the total production of healthcare profession in 2008, nursing and midwives are considered the key categories with significant manpower shortages.
The Indonesian government had introduced legislations for healthcare professionals to take up jobs in both the public and private sectors. While from the positive end, this human resource distribution trend may be viewed as a form of resource sharing, a negative impact such as diminishing service quality and less accountability for less incentivized public health service may arise due to the lack of oversight mechanisms for such practices. According to USAID, about 60 to 70.0 percent of healthcare workers in Indonesia currently hold dual employment in the public and private sectors.
Indonesian health ministry established a supervisory body, the Indonesian Hospitals Supervisory Agency (BPRSI), to eliminate irregularities in hospital care. This followed complaints about poor care and medical malpractice. Patients have reportedly received poor service due to a lack of set standards of procedures for services in hospitals in the country. The BPRSI will develop an oversight system to monitor operations in all public and private hospitals. The five member agency will also establish provincial supervisory bodies that will be managed by governors. It is also likely to monitor the proposed implementation of free third-class hospital care for all citizens in 2012.
University of Indonesia started the construction of a new hospital at its Depok campus in October 2011. The Japan International Cooperation Agency will provide loan to the university to build the IDR1.4trn (US$158.2mn) UI Hospital. According to the university rector, Gumilar Rusliwa Somantri, the hospital will be a world-class facility for education and a benchmark for hospitals in the region. The first phase of the construction will establish a new complex for the schools of medicine, dentistry and pharmacy by June 2012.New health service facilities are expected to be charged an enterprise income tax of 10% rather than the previous 28%, while the Vietnam Development Bank is likely to grant loans to projects that concern the expansion and building of new hospitals.
Singapore-based Thomson International and Pacific Healthcare, Malaysia-based Columbia Asia and the first private hospital in Vietnam, called the French Hospital of Hanoi, which is owned by the French company Eukaria S.A. As more patients resort to private hospitals, the government is likely to be forced to step up its facilities to ensure that quality healthcare is made available to the poorest of the poor.
Viet Government has drafted a plan that aims to modernize traditional medicine by 2020. According to the plan, hospitals that offer traditional alternatives to patients will receive new equipment in 2015. According to statistics provided by the Ministry of Health, about 30% of patients nationwide receive treatment from traditional practitioners, of which more than 70% patients recovered from their illnesses
More social. Business customers are exposed to the same dynamics of peer-to-peer networks and opinions that influence individual consumers. The equivalent of Facebook’s “like” button also applies to B2B sales. Many of the one-to-one relationships with key decision makers that sales executives historically relied on to close sales are shifting to one-to-many relationships. Moreover, the actions of important influencers (including senior executives) in the purchasing process are often less visible to suppliers. Customers may be “liking” or “not liking” a prospective offer long before the sales rep has even presented it. For example, an expert blogger with a wide following among, say, electrical engineers can shift perceptions of which supplier has the best next-generation networking equipment. Or a speaker at a trade show—her message amplified by her listeners through digital channels—may have an outsized impact on a CEO’s perceptions of market trends and their implications for different B2B suppliers.
More real-time. Flows of digital information have further democratized business procurement. Our research indicates nearly 50 percent of all B2B purchases will be made on digital platforms by the end of 2015, and expenditures for B2B digital advertising are expected to double by 2018. Empowered purchasers increasingly demand real- time digital interactions supported by tools such as product configurators and price calculators. And they are doing all this while texting, e-mailing, and talking regularly with on-the-ground sales teams, distributors, behind-the-scenes inside sales groups, customer-service call centers, and technical reps. Our research shows that, on average, a B2B customer will regularly use six different interaction channels throughout the decision journey, and almost 65 percent will come away from it frustrated by inconsistent experiences.
More modular. The game also is changing for closing deals with requests for proposals (RFPs). At one company, operations executives were looking to improve process efficiencies and assure better after-sales service. To increase their options, they overrode the purchasing department by requiring six rather than three bids for a product. They also demanded modular RFPs, so cross-functional teams could examine an offer’s details, such as service and financing. With so many gateways of influence, our research not surprisingly shows, two-thirds of B2B deals are lost before a formal RFP process even begins.
Value - market share
Voume - share of customer
the challenge of building customer loyalty, we need to break down shoppers into five main types:
Loyal Customers: They represent no more than 20 percent of our customer base, but make up more than 50 percent of our sales.
Discount Customers: They shop our stores frequently, but make their decisions based on the size of our markdowns.
Impulse Customers: They do not have buying a particular item at the top of their “To Do” list, but come into the store on a whim. They will purchase what seems good at the time.
Need-Based Customers: They have a specific intention to buy a particular type of item.
Wandering Customers: They have no specific need or desire in mind when they come into the store. Rather, they want a sense of experience and/or community
“Deals help justify unnecessary consumption”
“Faster product adoption leads to shorter lifecycle”
“Instant and experiential are no longer oxymoron”
“Idealism is natural counterbalance to consumerism”
“Local is the new sexy”
“I connect, therefore I am”
“Good life makes you have something to lose”
“Making choices feels good”
“My lifestyle doesn’t mean I’m not in shape (denial mode)”
The characteristics of companies that measure well
So what are the key metrics for measuring FFE effectively? Looking at
the common characteristics of companies recognised as having highperforming
sales teams, as researched by RMCI, provides a clue.
They understand demand – who their customer are, what they buy and
when they buy it. These metrics aligned with a robust segmentation process
deliver intelligence that allows companies to deploy their resources where
they are need the most.
They master product knowledge – today’s buyers are savvy, and sales
teams need to know their products and show thought leadership, not simply
be a trusted adviser.
They communicate business benefits – the impact the product or service
has on a business or the function it serves.
They use account plans – as part of sales incentive plans (SIPs) to drive
sales through effective reward and recognition.
They use differentiated metrics – recognition that ‘one size does not fit
all’ from a metrics perspective, resulting in different approaches for each
stakeholder or function, as well as measuring key items at various stages of
the sales process. www.mentorgroup.co.ukwww.mentorgroup.co.ukwww.mentorgroup.co.uk
Business Challenges: The Selling Environment
Competition is intense. Participants also cited new players entering their markets and old players
challenging traditional boundaries of service and product offerings. Differentiation was seen as crucial and
extremely hard to achieve.
Customers are more sophisticated, knowledgeable and demanding. This raises the bar for sales
interactions and requires salespeople to deliver value. Procurement departments are playing a stronger
role in the buying process today. Salespeople need to understand the value drivers in each buying center
and respond effectively.
Acquiring new customers and opening new channels were reported as increasingly important to
growth strategies. Often customer acquisition was tied to customer retention strategies that sought to
expand relationships and increase buying centers in existing accounts.
Profitability has replaced revenue growth as a critical focus of sales organizations. The sales force is
expected to achieve price targets and deliver margins—but also to be more consultative and solutionsoriented.
Commoditization/shrinking markets was a theme in most industries. There is a perceived need to
differentiate through value-added services, innovative product-applications, and insights about customers’
customers.
The roles of sales representative and sales manager are described as more complex and demanding.
The search for talent seemed universal, and expectations that the current sales force could achieve growth
targets were generally low.
All three sales skills correlated significantly with performance, in the following order:
Winning customers (.51)13
Finding customers (.49)
Keeping customers (.28)
Skills in finding and winning customers were highly correlated with sales force performance. In fact, of the 19
factors we considered, these two skills were the strongest predictors of success. While keeping customers
continued to be important, the skills that made the biggest difference in the new sales environment related to
expanding one’s “turf” by competing for new customers more than to retaining existing customers.
Sales Management Skills
On average, the sales executives did not rate their managers as having strong skills—the average rating was 6.8 out of 10. Executives attributed the relatively low ratings to different causes. In some cases managers were former top-performing salespeople who had been promoted due to their sales performance—not their management ability. In other cases the requirements of the sales manager role had changed, demanding a higher level of leadership and management skills than in the past. In general, sales executives viewed sales management as a major point of leverage for their organization and viewed management development as a critical need.
We considered three sales management skills: strategizing (that is, developing a strategy for the unit and helping reps think strategically about their accounts), motivating the sales force, and providing individual coaching and feedback. We had identified these skills in previous research as key success factors14. Although the ratings of both groups were relatively low on all three skills, the higher-performing group rated their managers as significantly stronger in each area—strategizing, motivating, and coaching—than they did the lower-performing group (see Exhibit 8).
The correlations of the three sales management skills with performance were:
Strategizing (.36)
Motivating (.34)
Coaching (.33)
The profile of the manager who is successful in driving performance is one of versatility. The manager must have analytical skills to develop strong business plans and also “people skills” to motivate the whole team and
provide developmental coaching and feedback to individual players.